(Q37842337)

24 August 2017

1 reference

title

Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus (English)

1 reference

24 August 2017

0 references

1 reference

1 reference

1

David W C Beasley

1 reference

24 August 2017

1 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

3

1 reference

24 August 2017

2

1 reference

24 August 2017

269-285

1 reference

Post-epidemic serosurvey of West Nile fever in Israel

24 August 2017

1 reference

Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey

21 January 2018

1 reference

Cost-effectiveness of West Nile virus vaccination

21 January 2018

1 reference

Flavivirus DNA vaccines--good science, uncertain future

21 January 2018

1 reference

Progress on the development of therapeutics against West Nile virus

21 January 2018

1 reference

Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses

21 January 2018

1 reference

Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development

21 January 2018

1 reference

West Nile virus: recent trends in diagnosis and vaccine development

21 January 2018

1 reference

Molecular targets for flavivirus drug discovery

21 January 2018

1 reference

Virus and Host Determinants of West Nile Virus Pathogenesis

21 January 2018

1 reference

The host immunologic response to West Nile encephalitis virus

21 January 2018

1 reference

Immunological headgear: antiviral immune responses protect against neuroinvasive West Nile virus

21 January 2018

1 reference

West Nile virus neuroinvasive disease

21 January 2018

1 reference

West Nile virus infections

21 January 2018

1 reference

Structure of West Nile Virus

21 January 2018

1 reference

The molecular biology of West Nile Virus: a new invader of the western hemisphere

21 January 2018

1 reference

West Nile Virus NS2B/NS3 protease as an antiviral target

21 January 2018

1 reference

End-to-end communication in the modulation of translation by mammalian RNA viruses

21 January 2018

1 reference

Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East

21 January 2018

1 reference

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

21 January 2018

1 reference

Genetic analysis of West Nile New York 1999 encephalitis virus

21 January 2018

1 reference

Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe

21 January 2018

1 reference

Clinical and pathologic features of lineage 2 West Nile virus infections in birds of prey in Hungary

21 January 2018

1 reference

Lineage 2 West Nile Virus as Cause of Fatal Neurologic Disease in Horses, South Africa

21 January 2018

1 reference

Transmission of West Nile virus during horse autopsy

21 January 2018

1 reference

West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa

21 January 2018

1 reference

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

21 January 2018

1 reference

Novel flavivirus or new lineage of West Nile virus, central Europe

21 January 2018

1 reference

West Nile virus isolates from India: evidence for a distinct genetic lineage.

21 January 2018

1 reference

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

21 January 2018

1 reference

Transfusion-transmitted infectious diseases

21 January 2018

1 reference

Transmission of West Nile virus through human breast milk seems to be rare.

21 January 2018

1 reference

Long-term prognosis for clinical West Nile virus infection

21 January 2018

1 reference

Long-term clinical and neuropsychological outcomes of West Nile virus infection

21 January 2018

1 reference

Persistent Infection with West Nile Virus Years after Initial Infection

21 January 2018

1 reference

Fatal hemorrhagic fever caused by West Nile virus in the United States

21 January 2018

1 reference

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

21 January 2018

1 reference

Protective immunity following vaccination: how is it defined?

21 January 2018

1 reference

Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005.

21 January 2018

1 reference

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

21 January 2018

1 reference

Crystal Structure of the West Nile Virus Envelope Glycoprotein

21 January 2018

1 reference

Antigenic structure of flavivirus proteins

21 January 2018

1 reference

Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus

21 January 2018

1 reference

Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

21 January 2018

1 reference

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

21 January 2018

1 reference

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

21 January 2018

1 reference

Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms

21 January 2018

1 reference

Isolation and characterization of selective and potent human Fab inhibitors directed to the active-site region of the two-component NS2B-NS3 proteinase of West Nile virus

21 January 2018

1 reference

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

21 January 2018

1 reference

Neutralization and antibody-dependent enhancement of dengue viruses

21 January 2018

1 reference

After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.

21 January 2018

1 reference

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

21 January 2018

1 reference

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

21 January 2018

1 reference

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

21 January 2018

1 reference

Treatment of West Nile Virus Encephalitis with Intravenous Immunoglobulin

21 January 2018

1 reference

West Nile virus neutralization by US plasma-derived immunoglobulin products

21 January 2018

1 reference

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

21 January 2018

1 reference

West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin

21 January 2018

1 reference

The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis

21 January 2018

1 reference

Persistent neuroinvasive West Nile virus infection in an immunocompromised patient

21 January 2018

1 reference

Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients

21 January 2018

1 reference

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

21 January 2018

1 reference

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

21 January 2018

1 reference

Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model

21 January 2018

1 reference

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody

21 January 2018

1 reference

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

21 January 2018

1 reference

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus

21 January 2018

1 reference

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

21 January 2018

1 reference

Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.

21 January 2018

1 reference

Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice

21 January 2018

1 reference

Genetically delivered antibody protects against West Nile virus

21 January 2018

1 reference

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

21 January 2018

1 reference

Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus

21 January 2018

1 reference

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse

21 January 2018

1 reference

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

21 January 2018

1 reference

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

21 January 2018

1 reference

A live, attenuated recombinant West Nile virus vaccine

21 January 2018

1 reference

Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.

21 January 2018

1 reference

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

21 January 2018

1 reference

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

21 January 2018

1 reference

Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys

21 January 2018

1 reference

The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus

21 January 2018

1 reference

Cross-protection between West Nile and Japanese encephalitis viruses in red-winged blackbirds (Agelaius phoeniceus).

21 January 2018

1 reference

Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.

21 January 2018

1 reference

Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice

21 January 2018

1 reference

Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine

21 January 2018

1 reference

The continuing spread of West Nile virus in the western hemisphere

21 January 2018

1 reference

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

21 January 2018

1 reference

Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex

21 January 2018

1 reference

Role of CD8+ T cells in control of West Nile virus infection

21 January 2018

1 reference

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes

21 January 2018

1 reference

Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection

21 January 2018

1 reference

Comparative Efficacies of Three Commercially Available Vaccines against West Nile Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine WNV Encephalitis Model

21 January 2018

1 reference

The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus

21 January 2018

1 reference

An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application

21 January 2018

1 reference

Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine

21 January 2018

1 reference

An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system

21 January 2018

1 reference

Avian virulence and thermostable replication of the North American strain of West Nile virus

21 January 2018

1 reference

Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells

21 January 2018

1 reference

Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis

21 January 2018

1 reference

Oral and parenteral immunization of chickens (Gallus gallus) against West Nile virus with recombinant envelope protein

21 January 2018

1 reference

Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).

21 January 2018

1 reference

A recombinant envelope protein vaccine against West Nile virus

21 January 2018

1 reference

A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells

21 January 2018

1 reference

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

21 January 2018

1 reference

Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.

21 January 2018

1 reference

A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity

21 January 2018

1 reference

The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization

21 January 2018

1 reference

Production and characterization of vaccines based on flaviviruses defective in replication

21 January 2018

1 reference

RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters

21 January 2018

1 reference

Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection

21 January 2018

1 reference

Identification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine Candidate

21 January 2018

1 reference

DNA vaccination of the American crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with West Nile virus

21 January 2018

1 reference

Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.

21 January 2018

1 reference

DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus).

21 January 2018

1 reference

Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice

21 January 2018

1 reference

Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.

21 January 2018

1 reference

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies

21 January 2018

1 reference

Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.

21 January 2018

1 reference

DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus

21 January 2018

1 reference

Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

21 January 2018

1 reference

West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II co

21 January 2018

1 reference

Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses

21 January 2018

1 reference

Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge

21 January 2018

1 reference

Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

21 January 2018

1 reference

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.

21 January 2018

1 reference

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

21 January 2018

1 reference

A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus

21 January 2018

1 reference

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine

21 January 2018

1 reference

Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses

21 January 2018

1 reference

ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy

21 January 2018

1 reference

Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model

21 January 2018

1 reference

Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes

21 January 2018

1 reference

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus

21 January 2018

1 reference

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

21 January 2018

1 reference

Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors

21 January 2018

1 reference

Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus

21 January 2018

1 reference

An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development

21 January 2018

1 reference

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

21 January 2018

1 reference

Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations

21 January 2018

1 reference

A Single Amino Acid Substitution in the West Nile Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit Alpha/Beta Interferon Induction and Attenuates Virus Virulence in Mice

21 January 2018

1 reference

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

21 January 2018

1 reference

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice

21 January 2018

1 reference

Selection of thioaptamers for diagnostics and therapeutics.

21 January 2018

1 reference

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections

21 January 2018

1 reference

West Nile virus infection in plasma of blood and plasma donors, United States

21 January 2018

1 reference

West Nile virus infections projected from blood donor screening data, United States, 2003

21 January 2018

1 reference

Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility

21 January 2018

1 reference

Emergence of attenuated West Nile virus variants in Texas, 2003.

21 January 2018

1 reference

Genome sequence and attenuating mutations in West Nile virus isolate from Mexico

21 January 2018

1 reference

Local impact of temperature and precipitation on West Nile virus infection in Culex species mosquitoes in northeast Illinois, USA.

21 January 2018

1 reference

Dry weather induces outbreaks of human West Nile virus infections

21 January 2018

1 reference

Rainy day reaction: human west nile viruses cases respond to weather patterns

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.10.93

1 reference

24 August 2017

1 reference

PubMed ID

21322763